We are analyzing https://link.springer.com/article/10.1007/s10549-009-0619-3.

Title:
Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment | Breast Cancer Research and Treatment
Description:
The concept of cancer cells being hierarchically organized and arising from their own progenitor stem cells will have important implications on cancer therapy. If this hypothesis were to be true then the paucity of estrogen receptors in stem cells as well as their inherent drug resistance mechanisms pose a challenge to current targeted therapies. In this study, we sought to examine the prognostic relevance of ALDH1, a putative cancer stem cell marker, by immunohistochemistry. The four cohorts analyzed included an adjuvantly treated series of 245 invasive cancers, a neoadjuvantly treated series of 34 cases, and two series of 58 and 40 triple negative cases, respectively. Both tumor cell and stromal expression for ALDH1 was evaluated, where possible. Tumor cell ALDH1 expression significantly correlated only with basal-like and HER2 tumor types in the adjuvant series and tumor grade in the neoadjuvant cohort. No significant enrichment for ALDH1 positive cells was observed in the postneoadjuvant therapy specimens compared to pretreatment samples. On the other hand, high degree of stromal expression was significantly associated with best disease-free survival as well as a trend for overall survival. The association of stromal expression was confirmed in an independent cohort of triple negative cases. The novel finding is that tumor microenvironment may play a significant role in determining the prognostic impact of stem/progenitor cells in human breast tumors.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,542,081 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure how the site profits.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

cancer, breast, article, google, scholar, cells, pubmed, stem, cas, cell, res, aldh, expression, tumor, research, prognostic, reisfilho, badve, access, clin, wicha, usa, pathology, privacy, cookies, content, microenvironment, resetkova, therapy, resistance, invasive, negative, human, natl, clarke, information, publish, search, impact, nakshatri, marker, series, cases, triple, basallike, aldehyde, dehydrogenase, markers, mammary, inst,

Topics {✒️}

month download article/chapter cancer stem cells—perspectives cd44−/cd24+ tumor cells cancer stem-cell hypothesis aldh1 positive cells triple negative cases reis-filho contributed equally adjuvant anthracycline-treated patients related subjects progenitor stem cells stem/progenitor cells cancer stem cells breast cancer cells invasive breast carcinomas human breast carcinoma human breast tumors full article pdf epithelial-mesenchymal transition breast cancer prevention breast cancer relates invasive breast carcinoma privacy choices/manage cookies her2 tumor types candidate target population metastatic breast cancer her2 gene amplification 245 invasive cancers breast cancers tumor microenvironment high aldehyde dehydrogenase cell mol med anderson cancer center epirubicin-based chemotherapy article resetkova neo-adjuvant chemotherapy cancer research estrogen receptors cd44+/cd24− phenotype reis-filho js distinct molecular signature stem cells european economic area cohorts analyzed included enhanced malignant rodriguez-pinilla sm asselin-labat ml aberrant luminal progenitors brca1 mutation carriers retinal oxidation activity cancer cells

Questions {❓}

O’Brien CS, Farnie G, Howell SJ, Clarke RB (2008) Are stem-like cells responsible for resistance to therapy in breast cancer?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment
         description:The concept of cancer cells being hierarchically organized and arising from their own progenitor stem cells will have important implications on cancer therapy. If this hypothesis were to be true then the paucity of estrogen receptors in stem cells as well as their inherent drug resistance mechanisms pose a challenge to current targeted therapies. In this study, we sought to examine the prognostic relevance of ALDH1, a putative cancer stem cell marker, by immunohistochemistry. The four cohorts analyzed included an adjuvantly treated series of 245 invasive cancers, a neoadjuvantly treated series of 34 cases, and two series of 58 and 40 triple negative cases, respectively. Both tumor cell and stromal expression for ALDH1 was evaluated, where possible. Tumor cell ALDH1 expression significantly correlated only with basal-like and HER2 tumor types in the adjuvant series and tumor grade in the neoadjuvant cohort. No significant enrichment for ALDH1 positive cells was observed in the postneoadjuvant therapy specimens compared to pretreatment samples. On the other hand, high degree of stromal expression was significantly associated with best disease-free survival as well as a trend for overall survival. The association of stromal expression was confirmed in an independent cohort of triple negative cases. The novel finding is that tumor microenvironment may play a significant role in determining the prognostic impact of stem/progenitor cells in human breast tumors.
         datePublished:2009-11-13T00:00:00Z
         dateModified:2009-11-13T00:00:00Z
         pageStart:97
         pageEnd:108
         sameAs:https://doi.org/10.1007/s10549-009-0619-3
         keywords:
            ALDH1
            Breast
            Stem cells
            Tumor microenvironment
            Chemotherapy
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-009-0619-3/MediaObjects/10549_2009_619_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-009-0619-3/MediaObjects/10549_2009_619_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-009-0619-3/MediaObjects/10549_2009_619_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-009-0619-3/MediaObjects/10549_2009_619_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-009-0619-3/MediaObjects/10549_2009_619_Fig5_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:123
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Erika Resetkova
               affiliation:
                     name:The University of Texas M. D. Anderson Cancer Center
                     address:
                        name:Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jorge S. Reis-Filho
               affiliation:
                     name:Institute of Cancer Research
                     address:
                        name:Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rohit K. Jain
               affiliation:
                     name:IU School of Medicine
                     address:
                        name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rutika Mehta
               affiliation:
                     name:IU School of Medicine
                     address:
                        name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mangesh A. Thorat
               affiliation:
                     name:IU School of Medicine
                     address:
                        name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Harikrishna Nakshatri
               affiliation:
                     name:IU School of Medicine
                     address:
                        name:Department of Surgery, Biochemistry and Molecular Biology, IU School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sunil Badve
               affiliation:
                     name:IU School of Medicine
                     address:
                        name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment
      description:The concept of cancer cells being hierarchically organized and arising from their own progenitor stem cells will have important implications on cancer therapy. If this hypothesis were to be true then the paucity of estrogen receptors in stem cells as well as their inherent drug resistance mechanisms pose a challenge to current targeted therapies. In this study, we sought to examine the prognostic relevance of ALDH1, a putative cancer stem cell marker, by immunohistochemistry. The four cohorts analyzed included an adjuvantly treated series of 245 invasive cancers, a neoadjuvantly treated series of 34 cases, and two series of 58 and 40 triple negative cases, respectively. Both tumor cell and stromal expression for ALDH1 was evaluated, where possible. Tumor cell ALDH1 expression significantly correlated only with basal-like and HER2 tumor types in the adjuvant series and tumor grade in the neoadjuvant cohort. No significant enrichment for ALDH1 positive cells was observed in the postneoadjuvant therapy specimens compared to pretreatment samples. On the other hand, high degree of stromal expression was significantly associated with best disease-free survival as well as a trend for overall survival. The association of stromal expression was confirmed in an independent cohort of triple negative cases. The novel finding is that tumor microenvironment may play a significant role in determining the prognostic impact of stem/progenitor cells in human breast tumors.
      datePublished:2009-11-13T00:00:00Z
      dateModified:2009-11-13T00:00:00Z
      pageStart:97
      pageEnd:108
      sameAs:https://doi.org/10.1007/s10549-009-0619-3
      keywords:
         ALDH1
         Breast
         Stem cells
         Tumor microenvironment
         Chemotherapy
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-009-0619-3/MediaObjects/10549_2009_619_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-009-0619-3/MediaObjects/10549_2009_619_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-009-0619-3/MediaObjects/10549_2009_619_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-009-0619-3/MediaObjects/10549_2009_619_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-009-0619-3/MediaObjects/10549_2009_619_Fig5_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:123
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Erika Resetkova
            affiliation:
                  name:The University of Texas M. D. Anderson Cancer Center
                  address:
                     name:Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jorge S. Reis-Filho
            affiliation:
                  name:Institute of Cancer Research
                  address:
                     name:Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rohit K. Jain
            affiliation:
                  name:IU School of Medicine
                  address:
                     name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rutika Mehta
            affiliation:
                  name:IU School of Medicine
                  address:
                     name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mangesh A. Thorat
            affiliation:
                  name:IU School of Medicine
                  address:
                     name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Harikrishna Nakshatri
            affiliation:
                  name:IU School of Medicine
                  address:
                     name:Department of Surgery, Biochemistry and Molecular Biology, IU School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sunil Badve
            affiliation:
                  name:IU School of Medicine
                  address:
                     name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:123
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The University of Texas M. D. Anderson Cancer Center
      address:
         name:Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:Institute of Cancer Research
      address:
         name:Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
         type:PostalAddress
      name:IU School of Medicine
      address:
         name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
         type:PostalAddress
      name:IU School of Medicine
      address:
         name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
         type:PostalAddress
      name:IU School of Medicine
      address:
         name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
         type:PostalAddress
      name:IU School of Medicine
      address:
         name:Department of Surgery, Biochemistry and Molecular Biology, IU School of Medicine, Indianapolis, USA
         type:PostalAddress
      name:IU School of Medicine
      address:
         name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Erika Resetkova
      affiliation:
            name:The University of Texas M. D. Anderson Cancer Center
            address:
               name:Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Jorge S. Reis-Filho
      affiliation:
            name:Institute of Cancer Research
            address:
               name:Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
               type:PostalAddress
            type:Organization
      name:Rohit K. Jain
      affiliation:
            name:IU School of Medicine
            address:
               name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
      name:Rutika Mehta
      affiliation:
            name:IU School of Medicine
            address:
               name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
      name:Mangesh A. Thorat
      affiliation:
            name:IU School of Medicine
            address:
               name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
      name:Harikrishna Nakshatri
      affiliation:
            name:IU School of Medicine
            address:
               name:Department of Surgery, Biochemistry and Molecular Biology, IU School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
      name:Sunil Badve
      affiliation:
            name:IU School of Medicine
            address:
               name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, USA
      name:Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
      name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
      name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
      name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
      name:Department of Surgery, Biochemistry and Molecular Biology, IU School of Medicine, Indianapolis, USA
      name:Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(129)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.8s.

LINK . SPRINGER . COM {}